← Leaderboards
Ross Leigh Cagan
Washington University
$25,056,984
Attributed
$27,467,677
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,467,677 · 10
By mechanism
R01$15,907,955 · 6
U54$10,275,796 · 1
R56$801,925 · 1
R21$462,001 · 1
R13$20,000 · 1
Top collaborators
- Arvin Dar6 shared
- Bruce D Gelb2 shared
Most similar at Washington University
Same institution · by research overlap
- John A Olson$6,092,537
- Jeffrey F Moley$810,481
- Sanjay Jain$27,367,157
- Terry C Lairmore$0
- Paul Joseph Goodfellow$8,639,266
Others in their field
Top investigators on “Drosophila Genus”
- Norbert Perrimon · Harvard Medical School$77,620,742
- Hugo J Bellen · Baylor College Of Medicine$32,341,526
- Susan E Celniker · University Of Calif-Lawrenc Berkeley Lab$32,260,987
- Craig Montell · University Of California Santa Barbara$30,891,067
- William Martin Gelbart · Harvard University$30,745,494
- Claude Desplan · New York University$23,033,750
Research focus
Drosophila GenusGeneticMalignant NeoplasmsMediatingPharmaceutical PreparationsGenetic ScreeningCellsPhenotypeLeadMutationComplexSignal TransductionLibrariesPathway InteractionsRetinaTumorDesignAnimalsTissuesBaseNovel TherapeuticsOrthologous GeneMutantGenes
Grant awards (58)
Therapy Development for Genetic Disorders of the RAS/MAPK Pathway$754,830
R01 · FY2025 · HL
Therapy Development for Genetic Disorders of the RAS/MAPK Pathway$759,920
R01 · FY2024 · HL
A Chemical Genetic Approach to Exploring Novel Therapeutic Space for Colorectal Cancer$622,641
R01 · FY2024 · CA
A Chemical Genetic Approach to Exploring Novel Therapeutic Space for Colorectal Cancer$504,213
R01 · FY2023 · CA
A Chemical Genetic Approach to Exploring Novel Therapeutic Space for Colorectal Cancer$138,561
R01 · FY2023 · CA
A Chemical Genetic Approach to Exploring Novel Therapeutic Space for Colorectal Cancer$604,219
R01 · FY2022 · CA
A Cytochrome P450 Therapeutic Space for Tauopathies$801,925
R56 · FY2021 · AG
A Chemical Genetic Approach to Exploring Novel Therapeutic Space for Colorectal Cancer$635,077
R01 · FY2021 · CA
A New Disease Platform Leveraging Complex Drosophila and Mammalian Models$1,987,420
U54 · FY2019 · OD · contact PI
A New Disease Platform Leveraging Complex Drosophila and Mammalian Models$1,988,127
U54 · FY2018 · OD · contact PI
A New Disease Platform Leveraging Complex Drosophila and Mammalian Models$423,750
U54 · FY2018 · OD · contact PI
A New Disease Platform Leveraging Complex Drosophila and Mammalian Models$1,888,720
U54 · FY2017 · OD · contact PI
A New Disease Platform Leveraging Complex Drosophila and Mammalian Models$1,987,779
U54 · FY2016 · OD · contact PI
A New Disease Platform Leveraging Complex Drosophila and Mammalian Models$2,000,000
U54 · FY2015 · OD · contact PI
A Drosophila Model Linking Diet-induced Obesity and Cancer (PQ 1)$351,713
R01 · FY2015 · CA · contact PI
Patterning within a Neuroepithelium$415,275
R01 · FY2014 · EY · contact PI
A Drosophila Model Linking Diet-induced Obesity and Cancer (PQ 1)$341,162
R01 · FY2014 · CA · contact PI
Patterning within a Neuroepithelium$402,563
R01 · FY2013 · EY · contact PI
A Drosophila Model Linking Diet-induced Obesity and Cancer (PQ 1)$330,610
R01 · FY2013 · CA · contact PI
A Drosophila model for Src-mediated oncogenesis$278,479
R01 · FY2013 · CA · contact PI
Patterning within a Neuroepithelium$423,750
R01 · FY2012 · EY · contact PI
A Drosophila Model Linking Diet-induced Obesity and Cancer (PQ 1)$351,713
R01 · FY2012 · CA · contact PI
A Drosophila model for Src-mediated oncogenesis$296,254
R01 · FY2012 · CA · contact PI
Patterning within a Neuroepithelium$423,750
R01 · FY2011 · EY · contact PI
A Drosophila model for Src-mediated oncogenesis$296,254
R01 · FY2011 · CA · contact PI
Patterning within a Neuroepithelium$407,347
R01 · FY2010 · EY · contact PI
A Drosophila model for Src-mediated oncogenesis$305,417
R01 · FY2010 · CA · contact PI
Patterning within a Neuroepithelium$411,461
R01 · FY2009 · EY · contact PI
A Drosophila model for Src-mediated oncogenesis$305,417
R01 · FY2009 · CA · contact PI
A Drosophila Model for MEN2 and Sporadic MTCs$236,780
R01 · FY2009 · CA · contact PI
Patterning within a Neuroepithelium$403,232
R01 · FY2008 · EY · contact PI
A Drosophila Model for Src-Mediated Oncogenesis$296,522
R01 · FY2008 · CA · contact PI
A Drosophila Model for MEN2 and Sporadic MTCs$236,780
R01 · FY2008 · CA · contact PI
Visual System Development 2008 Gordon Research Conference$20,000
R13 · FY2008 · EY · contact PI
Patterning within a Neuroepithelium$411,461
R01 · FY2007 · EY · contact PI
A Drosophila Model for MEN2 and Sporadic MTCs$236,780
R01 · FY2007 · CA · contact PI
A Drosophila Model for Src-Mediated Oncogenesis$225,174
R01 · FY2007 · CA · contact PI
A Drosophila Model for Src-Mediated Oncogenesis$65,067
R01 · FY2007 · CA · contact PI
Drosophila Screens for Diabetes and Glucose Toxicity$38,104
R21 · FY2007 · DK · contact PI
Patterning within a Neuroepithelium$381,250
R01 · FY2006 · EY · contact PI
A Drosophila Model for Src-Mediated Oncogenesis$275,651
R01 · FY2006 · CA · contact PI
A Drosophila Model for MEN2 and Sporadic MTCs$219,394
R01 · FY2006 · CA · contact PI
Drosophila Screens for Diabetes and Glucose Toxicity$117,897
R21 · FY2006 · DK · contact PI
Programmed Cell Death in the Drosophila Eye$346,500
R01 · FY2005 · EY
A Drosophila Model for Src-Mediated Oncogenesis$282,285
R01 · FY2005 · CA
Drosophila Screens for Diabetes and Glucose Toxicity$153,000
R21 · FY2005 · DK
Programmed Cell Death in the Drosophila Eye$346,500
R01 · FY2004 · EY
A Drosophila Model for Src-Mediated Oncogenesis$248,460
R01 · FY2004 · CA
A DROSOPHILA MODEL FOR MEN2B AND SPORADIC MTC$226,075
R01 · FY2004 · CA
Drosophila Screens for Diabetes and Glucose Toxicity$153,000
R21 · FY2004 · DK
Programmed Cell Death in the Drosophila Eye$346,500
R01 · FY2003 · EY
A DROSOPHILA MODEL FOR MEN2B AND SPORADIC MTC$219,493
R01 · FY2003 · CA
Programmed Cell Death in the Drosophila Eye$346,500
R01 · FY2002 · EY
A DROSOPHILA MODEL FOR MEN2B AND SPORADIC MTC$240,336
R01 · FY2002 · CA
Programmed Cell Death in the Drosophila Eye$346,500
R01 · FY2001 · EY
A DROSOPHILA MODEL FOR MEN2B AND SPORADIC MTC$207,226
R01 · FY2001 · CA
A DROSOPHILA MODEL FOR MEN2B AND SPORADIC MTC$225,082
R01 · FY2000 · CA
PROGRAMMED CELL DEATH IN THE DROSOPHILA EYE$177,781
R01 · FY2000 · EY